Skip to Main Content

Paper Details

IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.
Journal of Oncology
4
2022
Author NameAffiliation
Yong-Bing XiangPediatric Research Institute, Children's Hospital of Chongqing Medical University
  • 1 - 1

Datasets

Release 1.2